Skip to main content

Table 2 Means of outcome variables

From: The influences of Taiwan's generic grouping price policy on drug prices and expenditures: Evidence from analysing the consumption of the three most-used classes of cardiovascular drugs

  Pre-action Post-action Change after the action
  mean std. dev. mean std. dev.  
Exposure group
Beta blocking agents
   Dayexp 11.77 6.79 9.94 6.00 -15.55%
   Totalday 98.14 46.32 162.31 55.46 65.39%
   Totalexp 1170.62 961.11 1632.12 1141.81 39.42%
Calcium channel blockers, vascular effects
   Dayexp 21.67 7.59 20.21 6.84 -6.74%
   Totalday 101.55 45.30 161.79 55.38 59.32%
   Totalexp 2211.01 1293.61 3313.68 1641.13 49.87%
ACE inhibitors, plain
   Dayexp 23.16 10.06 21.75 9.25 -6.09%
   Totalday 100.21 48.50 154.67 58.88 54.35%
   Totalexp 2341.01 1743.67 3374.22 2101.87 44.14%
Comparison group
Beta blocking agents
   Dayexp 13.07 10.74 13.04 10.10 -0.23%
   Totalday 95.03 48.30 160.27 55.68 68.65%
   Totalexp 1287.80 1475.68 2117.25 1953.77 64.41%
Calcium channel blockers, vascular effects
   Dayexp 20.49 6.77 20.23 6.70 -1.27%
   Totalday 90.44 47.96 159.23 54.86 76.06%
   Totalexp 1840.81 1171.14 3259.82 1641.34 77.09%
ACE inhibitors, plain
   Dayexp 23.65 9.05 24.28 10.23 2.66%
   Totalday 101.27 48.03 154.38 57.18 52.44%
   Totalexp 2383.21 1539.46 3669.49 1994.09 53.97%